Science Explorer Back to mapMap
Discussion
Topic · Ophthalmology

Ocular Infections and Treatments

Ocular Infections and Treatments is a research topic within Ophthalmology. Science Explorer counts 20k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the epidemiology, risk factors, microbiological spectrum, antibiotic resistance, and management strategies for ocular infections such as endophthalmitis, keratitis, and fungal keratitis. It also explores the impact of cataract surgery and intravitreal injections on the development of these infections, as well as the composition of conjunctival flora.

  • Endophthalmitis
  • Keratitis
  • Ocular Infections
  • Antibiotic Resistance
  • Fungal Keratitis
  • Cataract Surgery
  • Microbial Spectrum
  • Intravitreal Injection
  • Conjunctival Flora
  • Corneal Blindness
Research works
20k
fractional, since 1950
In the world top 10%
2k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+5%
the tick is no change
Largest producer
United States
28% of the 10 largest, 2022-now

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Ocular Infections and Treatments research?

By volume, the United States and India publish the most (798 and 603 works in 2022-now).

By volume, 2022-now

  1. 1 United States 798 works
  2. 2 India 603 works
  3. 3 China 487 works
  4. 4 United Kingdom 204 works
  5. 5 Spain 137 works
  6. 6 Germany 137 works
  7. 7 Japan 125 works
  8. 8 Türkiye 120 works
  9. 9 Italy 118 works
  10. 10 South Korea 102 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 28.2%India: 21.3%China: 17.2%United Kingdom: 7.2%6 others listed: 26.1%28%largest
United States798 · 28.2%India603 · 21.3%China487 · 17.2%United Kingdom204 · 7.2%6 others listed739 · 26.1%

Shares of the rows listed above, not of the whole node.

Which institutions lead Ocular Infections and Treatments research?

By volume in 2022-now, L V Prasad Eye Institute publishes the most Ocular Infections and Treatments research, followed by All India Institute of Medical Sciences and Aravind Eye Hospital.

Who are the leading researchers in Ocular Infections and Treatments?

The most-cited researchers publishing on Ocular Infections and Treatments include Jost Bruno Jonas, Gordon Henry Guyatt and Rakhi Dandona.

  1. 1 Jost Bruno Jonas Germany 350k citations
  2. 2 Gordon Henry Guyatt Canada 315k citations
  3. 3 Rakhi Dandona United States 280k citations
  4. 4 Yousef Saleh Khader Jordan 274k citations
  5. 5 Hagop M. Kantarjian United States 273k citations
  6. 6 Cornelia M. van Duijn Netherlands 250k citations
  7. 7 Tien Yin Wong Singapore 237k citations
  8. 8 Kai You Wang China 224k citations
  9. 9 Tianjing Li United States 219k citations
  10. 10 Aziz Sheikh United Kingdom 214k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Ocular Infections and Treatments?

The most cited paper in Ocular Infections and Treatments is "Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis" (Raoul Herbrecht et al., 2002), with 3,326 citations. Next come "Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases" (3,065) and "Photodynamic therapy: a new antimicrobial approach to infectious disease?" (2,044).

Most cited papers
#PaperReleasedCitations
1 Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis Raoul Herbrecht et al. · New England Journal of Medicine Open access 8 Aug 2002 3,326
2 Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases Maureen M. Roden, Theoklis E. Zaoutis, Wendy L. Buchanan et al. · Clinical Infectious Diseases 5 Aug 2005 3,065
3 Photodynamic therapy: a new antimicrobial approach to infectious disease? Michael R. Hamblin, Tayyaba G. Hasan · Photochemical & Photobiological Sciences Open access 30 Apr 2004 2,044
4 Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses Shawn R. Lockhart, Kizee A. Etienne, Snigdha Vallabhaneni et al. · Clinical Infectious Diseases Open access 14 Oct 2016 1,713
5 Ranibizumab for Diabetic Macular Edema Quan Dong Nguyen, David M. Brown, Dennis M. Marcus et al. · Ophthalmology 11 Feb 2012 1,625
All 100 most cited papers, with filters and sorting

Where is Ocular Infections and Treatments research done?

The largest centres of Ocular Infections and Treatments research in 2022-now are Hyderabad (India), London (United Kingdom), Beijing (China) and New Delhi (India). Among places with at least 20 works in it, it is an unusually large share of all research in Madurai, Mountain View and Coral Gables.

Largest cities, 2022-now

  1. 1 HyderabadIndia 87 works
  2. 2 LondonUnited Kingdom 74 works
  3. 3 BeijingChina 73 works
  4. 4 New DelhiIndia 66 works
  5. 5 ChennaiIndia 51 works
  6. 6 SeoulSouth Korea 48 works
  7. 7 RiyadhSaudi Arabia 44 works
  8. 8 MaduraiIndia 44 works
  9. 9 TehranIran 41 works
  10. 10 MoscowRussia 41 works

Where it is the local speciality

  1. MaduraiIN · 43.8 works38×
  2. Mountain ViewUS · 29.6 works13×
  3. Coral GablesUS · 24.1 works12×
  4. HyderabadIN · 86.9 works11×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Ocular Infections and Treatments than the world average.

See Ocular Infections and Treatments on the map

Where is the best place to study Ocular Infections and Treatments?

Among universities, judged by research, Qingdao University, Johns Hopkins University and Wenzhou Medical University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 17.78%fractional works in this field (log) →share of work in the world top 10% →Qingdao UniversityWenzhou Medical Univ…Johns Hopkins Univer…University of Miami
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Qingdao UniversityChina 70.430.5%7.5×19 +10.2%
2Johns Hopkins UniversityUnited States 68.019.3%4.0×23 +7.3%
3Wenzhou Medical UniversityChina 62.323.0%8.2×16 +42.8%
4University of MiamiUnited States 61.815.7%11.9×28 -19.9%
5Harvard UniversityUnited States 59.614.4%2.7×33 -11.3%
6All India Institute of Medical SciencesIndia 58.85.3%13.3×56 +22.3%
7Fudan UniversityChina 56.621.1%2.8×17 +20.6%
8University College LondonUnited Kingdom 56.18.7%4.7×29 -6.5%
9UNSW SydneyAustralia 56.026.0%3.7×13 -34.8%
10Capital Medical UniversityChina 52.913.8%6.3×26 +32.8%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Ocular Infections and Treatments, country by country

Is Ocular Infections and Treatments research growing?

Output in 2022-2025 was 5% higher than in 2018-2021, peaking in 2026. The fastest-growing topics are Ocular Infections and Treatments.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Ocular Infections and Treatments as a percentage of every work published that year, 0.015% in 2024.

still counting0.010%0.020%0.030%Ocular Infections and Treatments0.016% in 202519801990200020102020

Fractional works of Ocular Infections and Treatments over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Ocular Infections and Treatments10.2% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Ocular Infections and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.